Peritoneal Neoplasms - 29 Studies Found
Completed |
: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer :
|
Completed |
: Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis :
|
Recruiting |
: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer :
|
Completed |
: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy :
|
Terminated |
: Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer :
|
Active, not recruiting |
: Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma : Liposarcoma : 2012-11-05 : Radiation: Radiotherapy Evaluation of the efficacy of the combination with radio-surgery helical tomothe |
Completed |
: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer :
|
Recruiting |
: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum :
: Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |